PFBT
LENZ

Parkside Financial Bank & Trust’s LENZ Therapeutics LENZ Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313 Hold
55
– – ﹤0.01% 2643
2026
Q1 		$504 Buy
+55
New +$773 ﹤0.01% 2568

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Parkside Financial Bank & Trust's LENZ Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 55 shares worth $313. The position accounts for ﹤0.01% of the portfolio, ranked #2643.

Parkside Financial Bank & Trust first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. The position peaked at $504 in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Parkside Financial Bank & Trust held 55 shares of LENZ Therapeutics worth $313 as of Q2 2026.
  • Parkside Financial Bank & Trust left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2643 holding.
  • Parkside Financial Bank & Trust first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Parkside Financial Bank & Trust's LENZ Therapeutics position peaked at $504 in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.